openPR Logo
Press release

Neurotrophic Keratitis Market demonstrates a spectacular growth by 2027 according to new research report

06-13-2019 10:50 AM CET | Health & Medicine

Press release from: Credence Research

Neurotrophic Keratitis Market demonstrates a spectacular

The latest market report published by Credence Research, Inc. “Global neurotrophic keratitis Market - Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global neurotrophic keratitis market is expected to expand at a CAGR of 5.2% from 2019 to 2027.

Market Insights
Ophthalmologist are currently employing the healing pathway of nerve growth factor (NGF) which is a neurotrophin that initiates neuronal sprouting by injured and intact neurons, a landmark discovery made by R. Levi Montalcini a nobel laureate. The human cornea produces high affinity NGF receptors which plays an important role in stimulating both survival and proliferation of epithelial and nerve fibres. Oxervate follows this pathway to treat neurotrophic keratitis across all age group.

Neurotrophic keratitis is an orphan disease with a global prevalence rate of 5 per 10,000 people. It is manifested by the damage of trigeminal nucleus nerve innervations present in the eye corneal region which dampens the healing process of corneal injuries. The treatment approach is adopted as per the different stages of the disease. Artificial tears are recommended in all the phases to ensure wetness, cleanliness and lubrication of the corneal surface. Topical antibiotics are prescribed in the stage 2 of the disease as a preventive measure against bacterial infection. In stage 3 surgical procedures such as Tarsorraphy, and amniotic membrane transplantation are preferred to treat corneal ulcers. Recent approval of Oxervate a recombinant human nerve growth factor by EMA and USFDA will bolster the neurotrophic market growth during the forecast period.

Browse the full report Neurotrophic Keratitis Market - Growth, Future Prospects, Competitive Analysis, 2019 – 2027 report at https://www.credenceresearch.com/report/neurotrophic-keratitis-market

North America is responsible for 33% market share and is currently the largest regional segment in neurotrophic keratitis market. As per the research findings brought forward by the American Academy of Ophthalmology (AAO), approximately 65,000 U.S. citizens are reported to be suffering with neurotrophic keratitis. Affordable reimbursement scenario propels the neurotrophic keratitis market growth in North America region. Europe trails North America and accounts for 28.5% market growth primarily due to strategic collaboration between academic research institute and pharmaceutical giants to develop novel drugs for the treatment of neurotrophic keratitis. European Medical Agency (EMA) has awarded orphan disease status to neurotrophic keratitis and has expedited its drug development and sale propaganda in the EU market. Asia Pacific holds 16% market share owing to the rising prevalence of neurotrophic keratitis in geriatric population and rampant growth in ophthalmology in the region over the last decade.
Pharmaceutical companies specializing in providing medication for the treatment of neurotrophic keratitis are Allergan, Plc., Abbott Laboratories, Inc., Bausch & Lomb Incorporated, Bayer AG, CooperVision, Dompe farmaceutici S.p.A., Johnson & Johnson, Novartis AG, ReGenTree, LLC., and Walgreens.

Key Market Movements:
• Rising prevalence of neurotrophic keratitis worldwide
• Supportive regulatory scenario provided for the growth of neurotrophic keratitis market by the healthcare agencies throughout the globe
• Recent approval by EMA and priority review designation awarded by the USFDA will help to flourish the Oxervate market for the treatment of neurotrophic keratitis in North America and Europe

Full Report: https://www.credenceresearch.com/sample-request/59723

Medium: https://medium.com/@CredenceResearc/neurotrophic-keratitis-market-north-america-is-responsible-for-33-market-share-432cd8d4f1ac

Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290
Email: sales@credenceresearch.com

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurotrophic Keratitis Market demonstrates a spectacular growth by 2027 according to new research report here

News-ID: 1773156 • Views:

More Releases from Credence Research

Pharmacy Market Size, Growth | Industry Report, 2023-2032
Pharmacy Market Size, Growth | Industry Report, 2023-2032
The latest market report published by Credence Research, Inc. The demand for the US Retail Pharmacy Market, valued at USD 569.79 Billion in 2023, is projected to soar to USD 948.80 Billion by 2032, marking a robust compound annual growth rate (CAGR) of 5.76% during the period from 2024 to 2032. The US retail pharmacy market stands as a cornerstone of the nation's healthcare infrastructure, serving as the frontline for patient
Medical Headgears Market is Expected to Reach USD 2,184.62 million by 2032 | Credence Research
Medical Headgears Market is Expected to Reach USD 2,184.62 million by 2032 | Cre …
The Medical Headgears Market is poised for substantial growth, with a market value of USD 1,247.86 million in 2024 projected to surge to USD 2,184.62 million by 2032, representing a robust compound annual growth rate (CAGR) of 6.36%. In the realm of healthcare, innovation is key, and this holds true for the field of medical headgears. These devices play a crucial role in various medical applications, from orthodontics to craniofacial
Quality Management Software Market Size, Share, Analysis, Growth & Forecast 2030
Quality Management Software Market Size, Share, Analysis, Growth & Forecast 2030
The latest market report published by Credence Research, Inc. The global demand for Quality Management Software market was valued at USD 9654.8 Million in 2023 and is expected to reach USD 24697.3 Million in 2032, growing at a CAGR of 11.00% between 2024 and 2032. In today's fast-paced and highly competitive business landscape, ensuring the highest level of product or service quality is paramount. Quality management is not just a goal
Commercial Drone Market Size, Growth to Reach USD 56756.3 Million by 2030 | Credence Research
Commercial Drone Market Size, Growth to Reach USD 56756.3 Million by 2030 | Cred …
The latest market report published by Credence Research, Inc. The global demand for Commercial Drone was valued at USD 19482.5 Million in 2022 and is expected to reach USD 56756.3 Million in 2030, growing at a CAGR of 14.30% between 2023 and 2030. In recent years, the commercial drone market has experienced exponential growth, revolutionizing industries and opening up new possibilities for businesses across the globe. From agriculture and construction to

All 5 Releases


More Releases for Neurotrophic

Neurotrophic Keratitis Market Growth Set to Surge Significantly during 2019 - 20 …
Neurotrophic Keratitis Market: Introduction Transparency Market Research has published a new report titled, "Global Neurotrophic Keratitis Market". According to the report, the global neurotrophic keratitis market was valued at US$ 91.6 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. Rise in reported cases of keratitis, increase in research & developmental activities, surge in awareness, and rise in co-morbidities & risk factors boost
Neurotrophic Keratitis Market to Register Substantial Expansion by 2024
Neurotrophic Keratitis Market: Introduction Transparency Market Research has published a new report titled, "Global Neurotrophic Keratitis Market". According to the report, the global neurotrophic keratitis market was valued at US$ 91.6 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. Rise in reported cases of keratitis, increase in research & developmental activities, surge in awareness, and rise in co-morbidities & risk factors boost
Neurotrophic Keratitis Market Trends 2021 | Segmentation, Outlook, Industry Repo …
The Neurotrophic Keratitis Market size is expected to grow at an annual average of 4% during 2021-2027. Neurotrophic keratitis (NK) is a neurodegenerative disease caused by damage to the trigeminal nerve that affects the cornea of the eye. In this disease, the patient decreases the sensitivity of the cornea, so the cornea is not damaged without treatment. If this disease is not properly treated and diagnosed, patients can lose permanent
Neurotrophic Keratitis Market Analysis By Industry Size, Share, Revenue Growth a …
Neurotrophic keratitis market is set to highlight rapid growth at a compounded annual growth rate (CAGR) of 5 % during the forecast period from 2021 to 2027. Neurotrophic keratitis (NK) is a neurodegenerative disease caused by damage to the trigeminal nerve that affects the cornea of the eye. In this disease, the patient decreases the sensitivity of the cornea, so the cornea is not damaged without treatment. If this disease is
Neurotrophic Keratitis Market - Global Industry Analysis, Size, Share, Growth, C …
TMR’s report on the global neurotrophic keratitis market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period of 2019–2027. The report provides the revenue of the global neurotrophic keratitis market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate
Neurotrophic Keratitis Market Growth, Trends, Share, Industry Size and Forecast …
Neurotrophic keratitis (NK) is a neurodegenerative disease caused by damage to the trigeminal nerve that affects the cornea of the eye. In this disease, the patient decreases the sensitivity of the cornea, so the cornea is not damaged without treatment. If this disease is not properly treated and diagnosed, patients can lose permanent vision. Treatment of neurotrophic keratitis is done by a team of neurologists, ophthalmologists, and corneal specialists. Treatment